Skip to content

JUVEDERM ULTRA XC 96207Recalls & reported problems

Allergan, Inc. · Juvéderm ULTRA XC 2x0.55mL · Class 3 · Implant

All models of JUVEDERM ULTRA XC (3)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10888628044760), received between Aug 20, 2026 and Aug 20, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Improper or Incorrect Procedure or Method1

Patient problems

  • Obstruction/Occlusion1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 20, 2026Improper or Incorrect Procedure or Method

    A healthcare professional reported that a patient was injected with 0.1mL of JUVÉDERM® Ultra XC In the lip. 2 hours later, the patient experienced swelling and blanching in the upper right lip quadrant. The patient was treated with 3 rounds of hylanex, aspirin, a heat pad, BBL C02, and hyperbaric chamber therapy. The event fully resolved after one week.

    Patient problems: Obstruction/Occlusion

    MAUDE report 50349656 ↗

Other Implant, Dermal, For Aesthetic Use devices

All Implant, Dermal, For Aesthetic Use devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page